Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients
Phase 4
Completed
- Conditions
- Corneal Staining
- Registration Number
- NCT00518700
- Lead Sponsor
- Innovative Medical
- Brief Summary
To compare corneal staining after contact lens instillation with a new MPS vs. RepleniSH
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Patients 18 yrs or older
- Males or females
- Any race or ethnic background
- CL patients using MPS products currently
- Patients using Contact Lenses habitually (at least 1 month)
Exclusion Criteria
- Corneal refractive surgery within 6 months of this study.
- Contact lens use on day of examination.
- Corneal ectasia.
- Current use of Restasis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms differentiate the new MPS from RepleniSH in reducing corneal staining in contact lens users?
How does the new MPS compare to standard-of-care solutions like RepleniSH in terms of ocular surface health and comfort metrics?
Are there specific biomarkers that correlate with improved corneal staining outcomes in contact lens patients using MPS formulations?
What adverse events are associated with the new MPS in contact lens wearers compared to RepleniSH?
What are the current trends in multipurpose solution development for managing corneal staining in contact lens users?
Trial Locations
- Locations (1)
Private Practice
🇺🇸Azusa, California, United States
Private Practice🇺🇸Azusa, California, United States